Skip to main content

Advertisement

SpringerLink
Log in

The molecular genetics of eyelid tumors: recent advances and future directions

  • Review article
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Background

Unprecedented recent advances in the molecular genetics of cutaneous malignancies have markedly improved our ability to diagnose, treat, and counsel patients with skin tumors. This review provides an update on molecular genetics of periocular cutaneous basal cell carcinoma, squamous cell carcinoma, sebaceous carcinoma, Merkel cell carcinoma, and malignant melanoma and describes how the knowledge of molecular genetics is translated into clinical practice.

Methods

A literature search of peer-reviewed and indexed publications from 1965 to 2012 using the PubMed search engine was performed. Key terms included: molecular genetics, eyelid, basal cell carcinoma, squamous cell carcinoma, sebaceous adenoma, sebaceous epithelioma, sebaceoma, sebaceous carcinoma, Merkel cell carcinoma, and melanoma. Seminal articles prior to 1965 were selected from primary sources and reviews from the initial search. Articles were chosen based on pertinence to clinical, genetic, and therapeutic topics reviewed in this manuscript.

Results

We reviewed the literature regarding the advances in molecular genetics of cutaneous basal cell carcinoma, squamous cell carcinoma, sebaceous neoplasia, Merkel cell carcinoma, and malignant melanoma, and possible future directions towards diagnosing and treating cutaneous tumors at the genetic level. Cell culture experiments, animal models, and molecular genetic studies on the patients’ tumor tissues helped to elucidate genetic aberrations in these lesions. Cell culture experiments, animal studies and, ultimately, clinical trials provided means to test and develop novel therapeutic strategies, namely targeted therapy directed at specific molecular genetic defects. While remarkable progress has been made in this process, the complexity of the molecular genetics of skin tumors makes complete elucidation of the genetic mechanisms and the search for ideal therapies challenging.

Conclusions

The recent studies focusing on molecular genetics of cutaneous malignancies show promising results, thereby improving our ability to diagnose, treat and counsel patients with these lesions. Future studies will hopefully help unravel further molecular mechanisms involved in cutaneous neoplasia and provide insights into novel preventative and therapeutic modalities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12
Fig. 13
Fig. 14

Similar content being viewed by others

References

  1. Tsao H (2001) Genetics of nonmelanoma skin cancer. Arch Dermatol 137:1486–1492

    PubMed  CAS  Google Scholar 

  2. Meyer T (2009) Molecular events in skin cancer. Cancer Treat Res 146:189–192

    Article  PubMed  CAS  Google Scholar 

  3. Gerami P, Zembowicz A (2011) Update on fluorescence in situ hybridization in melanoma: state of the art. Arch Pathol Lab Med 135:830–837

    PubMed  Google Scholar 

  4. Bauer J, Bastian BC (2006) Distinguishing melanocytic nevi from melanoma by DNA copy number changes: comparative genomic hybridization as a research and diagnostic tool. Dermatol Ther 19:40–49

    Article  PubMed  Google Scholar 

  5. Blokx WA, van Dijk MC, Ruiter DJ (2010) Molecular cytogenetics of cutaneous melanocytic lesions—diagnostic, prognostic and therapeutic aspects. Histopathology 56:121–132

    Article  PubMed  Google Scholar 

  6. Abbas O, Mahalingam M (2009) Cutaneous sebaceous neoplasms as markers of Muir-Torre syndrome: a diagnostic algorithm. J Cutan Pathol 36:613–619

    Article  PubMed  Google Scholar 

  7. Iwasaki JK, Srivastava D, Moy RL, Lin HJ, Kouba DJ (2010) The molecular genetics underlying basal cell carcinoma pathogenesis and links to targeted therapeutics. J Am Acad Dermatol 66:e167–e178

    Article  PubMed  Google Scholar 

  8. Davies MA, Samuels Y (2010) Analysis of the genome to personalize therapy for melanoma. Oncogene 29:5545–5555

    Article  PubMed  CAS  Google Scholar 

  9. Schrama D, Ugurel S, Becker JC (2012) Merkel cell carcinoma: recent insights and new treatment options. Curr Opin Oncol 24:141–149

    Article  PubMed  Google Scholar 

  10. Ly TY, Walsh NM, Pasternak S (2012) The spectrum of Merkel cell polyomavirus expression in Merkel cell carcinoma, in a variety of cutaneous neoplasms, and in neuroendocrine carcinomas from different anatomical sites. Hum Pathol 43:557–566

    Article  PubMed  CAS  Google Scholar 

  11. Bhatia S, Afanasiev O, Nghiem P (2011) Immunobiology of Merkel cell carcinoma: implications for immunotherapy of a polyomavirus-associated cancer. Curr Oncol Rep 13:488–497

    Article  PubMed  CAS  Google Scholar 

  12. Meyer T (2009) Molecular pathogenesis of basal cell carcinoma. Cancer Treat Res 146:193–204

    Article  PubMed  CAS  Google Scholar 

  13. Prabhakaran VC, Gupta A, Huilgol SC, Selva D (2007) Basal cell carcinoma of the eyelids. Compr Ophthalmol Update 8:1–14

    PubMed  Google Scholar 

  14. de Zwaan SE, Haass NK (2010) Genetics of basal cell carcinoma. Australas J Dermatol 51:81–94

    Article  PubMed  Google Scholar 

  15. Lorz C, Segrelles C, Paramio JM (2009) On the origin of epidermal cancers. Curr Mol Med 9:353–364

    Article  PubMed  Google Scholar 

  16. Scherer D, Kumar R (2010) Genetics of pigmentation in skin cancer—a review. Mutat Res 705:141–153

    Article  PubMed  CAS  Google Scholar 

  17. Lynde CW, Sapra S (2010) Predictive testing of the melanocortin 1 receptor for skin cancer and photoaging. Skin Therapy Lett 15:5–7

    PubMed  CAS  Google Scholar 

  18. Rudin CM (2012) Vismodegib. Clin Cancer Res 18:3218–3222

  19. Mehta M, Fay A (2009) Squamous cell carcinoma of the eyelid and conjunctiva. Int Ophthalmol Clin 49:111–121

    Article  PubMed  Google Scholar 

  20. Nindl I, Rösl F (2009) Molecular pathogenesis of squamous cell carcinoma. Cancer Treat Res 146:205–211

    Article  PubMed  CAS  Google Scholar 

  21. Rodust PM, Stockfleth E, Ulrich C, Leverkus M, Eberle J (2009) UV-induced squamous cell carcinoma—a role for antiapoptotic signalling pathways. Br J Dermatol 3:107–115

    Article  Google Scholar 

  22. Kern F, Niault T, Baccarini M (2010) Ras and Raf pathways in epidermis development and carcinogenesis. Br J Cancer 104:229–234

    Article  PubMed  Google Scholar 

  23. Eckert RL, Adhikary G, Rorke EA, Chew YC, Balasubramanian S (2011) Polycomb group proteins are key regulators of keratinocyte function. J Invest Dermatol 131:295–301

    Article  PubMed  CAS  Google Scholar 

  24. Shields JA, Shields CL (2009) Sebaceous adenocarcinoma of the eyelid. Int Ophthalmol Clin 49:45–61

    Article  PubMed  Google Scholar 

  25. Kiyosaki K, Nakada C, Hijiya N, Tsukamoto Y, Matsuura K, Nakatsuka K, Daa T, Yokoyama S, Imaizumi M, Moriyama M (2010) Analysis of p53 mutations and the expression of p53 and p21WAF1/CIP1 protein in 15 cases of sebaceous carcinoma of the eyelid. Invest Ophthalmol Vis Sci 51:7–11

    Article  PubMed  Google Scholar 

  26. Rishi K, Font RL (2004) Sebaceous gland tumors of the eyelids and conjunctiva in the Muir-Torre syndrome: a clinicopathologic study of five cases and literature review. Ophthal Plast Reconstr Surg 20:31–36

    Article  PubMed  Google Scholar 

  27. Schwartz RA, Torre DP (1995) The Muir-Torre syndrome: a 25-year retrospect. J Am Acad Dermatol 33:90–104

    Article  PubMed  CAS  Google Scholar 

  28. Gaskin BJ, Fernando BS, Sullivan CA, Whitehead K, Sullivan TJ (2011) The significance of DNA mismatch repair genes in the diagnosis and management of periocular sebaceous cell carcinoma and Muir-Torre syndrome. Br J Ophthalmol 95:1686–1690

    Article  PubMed  Google Scholar 

  29. Singh RS, Grayson W, Redston M, Diwan AH, Warneke CL, McKee PH, Lev D, Lyle S, Calonje E, Lazar AJ (2008) Site and tumor type predicts DNA mismatch repair status in cutaneous sebaceous neoplasia. Am J Surg Pathol 32:936–942

    Article  PubMed  Google Scholar 

  30. Orta L, Klimstra DS, Qin J, Mecca P, Tang LH, Busam KJ, Shia J (2009) Towards identification of hereditary DNA mismatch repair deficiency: sebaceous neoplasm warrants routine immunohistochemical screening regardless of patient’s age or other clinical characteristics. Am J Surg Pathol 33:934–944

    Article  PubMed  Google Scholar 

  31. Mojtahed A, Schrijver I, Ford JM, Longacre TA, Pai RK (2011) A two-antibody mismatch repair protein immunohistochemistry screening approach for colorectal carcinomas, skin sebaceous tumors, and gynecologic tract carcinomas. Mod Pathol 24:1004–1014

    Article  PubMed  Google Scholar 

  32. Loukola A, Eklin K, Laiho P, Salovaara R, Kristo P, Järvinen H, Mecklin JP, Launonen V, Aaltonen LA (2001) Microsatellite marker analysis in screening for hereditary nonpolyposis colorectal cancer (HNPCC). Cancer Res 61:4545–4549

    PubMed  CAS  Google Scholar 

  33. Kumar A, Kumar Dorairaj S, Prabhakaran VC, Prakash DR, Chakraborty S (2007) Identification of genes associated with tumorigenesis of meibomian cell carcinoma by microarray analysis. Genomics 90:559–566

    Article  PubMed  CAS  Google Scholar 

  34. Kuwamoto S (2011) Recent advances in the biology of Merkel cell carcinoma. Hum Pathol 42:1063–1077

    Article  PubMed  CAS  Google Scholar 

  35. Wong HH, Wang J (2010) Merkel cell carcinoma. Arch Pathol Lab Med 134:1711–1716

    PubMed  Google Scholar 

  36. Donepudi S, DeConti RC, Samlowski WE (2012) Recent advances in the understanding of the genetics, etiology, and treatment of Merkel cell carcinoma. Semin Oncol 39:163–172

    Article  PubMed  CAS  Google Scholar 

  37. Feng H, Shuda M, Chang Y, Moore PS (2008) Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 319:1096–10100

    Article  PubMed  CAS  Google Scholar 

  38. Gjoerup O, Chang Y (2010) Update on human polyomaviruses and cancer. Adv Cancer Res 106:1–51

    Article  PubMed  CAS  Google Scholar 

  39. White MK, Safak M, Khalili K (2009) Regulation of gene expression in primate polyomaviruses. J Virol 83:10846–10856

    Article  PubMed  CAS  Google Scholar 

  40. Houben R, Schrama D, Becker JC (2009) Molecular pathogenesis of Merkel cell carcinoma. Exp Dermatol 18:193–198

    Article  PubMed  CAS  Google Scholar 

  41. Busam KJ, Jungbluth AA, Rekthman N, Coit D, Pulitzer M, Bini J, Arora R, Hanson NC, Tassello JA, Frosina D, Moore P, Chang Y (2009) Merkel cell polyomavirus expression in merkel cell carcinomas and its absence in combined tumors and pulmonary neuroendocrine carcinomas. Am J Surg Pathol 33:1378–1385

    Article  PubMed  Google Scholar 

  42. Schulz TF (2009) Cancer and viral infections in immunocompromised individuals. Int J Cancer 125:1755–1763

    Article  PubMed  CAS  Google Scholar 

  43. Paik JY, Hall G, Clarkson A, Lee L, Toon C, Colebatch A, Chou A, Gill AJ (2011) Immunohistochemistry for Merkel cell polyomavirus is highly specific but not sensitive for the diagnosis of Merkel cell carcinoma in the Australian population. Hum Pathol 42:1385–1390

    Article  PubMed  Google Scholar 

  44. Duncavage EJ, Le BM, Wang D, Pfeifer JD (2009) Merkel cell polyomavirus: a specific marker for Merkel cell carcinoma in histologically similar tumors. Am J Surg Pathol 33:1771–1777

    Article  PubMed  Google Scholar 

  45. Sihto H, Kukko H, Koljonen V, Sankila R, Böhling T, Joensuu H (2009) Clinical factors associated with Merkel cell polyomavirus infection in Merkel cell carcinoma. J Natl Cancer Inst 101:938–945

    Article  PubMed  CAS  Google Scholar 

  46. Zeng Q, Gomez BP, Viscidi RP, Peng S, He L, Ma B, Wu TC, Hung CF (2012) Development of a DNA vaccine targeting Merkel cell polyomavirus. Vaccine 30:1322–1329

    Article  PubMed  CAS  Google Scholar 

  47. Sanchez R, Ivan D, Esmaeli B (2009) Eyelid and periorbital cutaneous malignant melanoma. Int Ophthalmol Clin 49:25–43

    Article  PubMed  Google Scholar 

  48. Boulos PR, Rubin PA (2006) Cutaneous melanomas of the eyelid. Semin Ophthalmol 21:195–206

    Article  PubMed  Google Scholar 

  49. Vaziri M, Buffam FV, Martinka M, Oryschak A, Dhaliwal H, White VA (2002) Clinicopathologic features and behavior of cutaneous eyelid melanoma. Ophthalmology 109:901–908

    Article  PubMed  Google Scholar 

  50. Takata M, Murata H, Saida T (2010) Molecular pathogenesis of malignant melanoma: a different perspective from the studies of melanocytic nevus and acral melanoma. Pigment Cell Melanoma Res 23:64–71

    Article  PubMed  CAS  Google Scholar 

  51. Palmieri G, Capone M, Ascierto ML, Gentilcore G, Stroncek DF, Casula M, Sini MC, Palla M, Mozzillo N, Ascierto PA (2009) Main roads to melanoma. J Transl Med 14:86

    Article  Google Scholar 

  52. Tsao H, Chin L, Garraway LA, Fisher DE (2012) Melanoma: from mutations to medicine. Genes Dev 26:1131–1155

    Article  PubMed  CAS  Google Scholar 

  53. Smalley KS, McArthur GA (2012) The current state of targeted therapy in melanoma: this time it’s personal. Semin Oncol 39:204–214

    Article  PubMed  CAS  Google Scholar 

  54. Nazarian R, Shi H, Wang Q, Kong X, Koya RC, Lee H, Chen Z, Lee MK, Attar N, Sazegar H, Chodon T, Nelson SF, McArthur G, Sosman JA, Ribas A, Lo RS (2010) Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation. Nature 468:973–977

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The New York Eye and Ear Infirmary, 310 East 14th Street, New York, NY, 10003, USA

    Tatyana Milman & Steven A. McCormick

  2. New York Medical College, Valhalla, NY, USA

    Tatyana Milman & Steven A. McCormick

Authors
  1. Tatyana Milman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Steven A. McCormick
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tatyana Milman.

Additional information

This work has been supported in part by the NYEEI Pathology Research Fund (Dr. Milman)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Milman, T., McCormick, S.A. The molecular genetics of eyelid tumors: recent advances and future directions. Graefes Arch Clin Exp Ophthalmol 251, 419–433 (2013). https://doi.org/10.1007/s00417-012-2248-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-012-2248-5

Keywords

Search

Navigation